News

Drug Delivery & Formulation,Manufacturing & Supply Chain,Research & Development
Evonik invests €93M in new GMP LNP manufacturing facility
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Kazia reports 83% response rate for paxalisib in triple-negative breast cancer
read more
Central Nervous System,Drug Discovery & Development,Research & Development,Therapeutic Areas
$3M funding targets tau-driven neurodegenerative diseases
read more
Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Cancer vaccine research secures $2.5M NIH award for nanoparticle treatment
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics
FDA approves Protagonist’s Mimrylo for polycythemia vera, triggering $275M in payments
read more
Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Isomab data support safety of angiogenic approaches in coronary artery disease
read more
Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
FDA approves Tivicay PD for children with HIV weighing at least 2kg
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
Tezspire meets Phase 3 endpoints in eosinophilic esophagitis
read more
Biotech & Pharma Business,Manufacturing & Supply Chain
Brenntag signs Eastern Europe nutraceutical distribution deal
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics
FDA approves daraxonrasib for second-line pancreatic cancer
read more
Biotech & Pharma Business,Digital & Data
PharmaForceIQ launches AI platform for pharma commercial teams
read more
Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics
Biogen’s felzartamab approved in China for multiple myeloma
read more
Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development
Agenus reports deep responses with immunotherapy in Phase 2 colon cancer study
read more
Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Research & Development
CEPI funds Minapharm’s Phase 1 Bundibugyo Ebola vaccine programme
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development
Sagimet prepares Phase 3 acne trial for first US patients
read more
Advanced Therapies,Drug Delivery & Formulation,Drug Discovery & Development,Research & Development
Circio and Full Circles Therapeutics combine technologies for in vivo cell therapy
read more

Evonik invests €93M in new GMP LNP manufacturing facility

Kazia reports 83% response rate for paxalisib in triple-negative breast cancer

$3M funding targets tau-driven neurodegenerative diseases

Cancer vaccine research secures $2.5M NIH award for nanoparticle treatment

FDA approves Protagonist’s Mimrylo for polycythemia vera, triggering $275M in payments

Isomab data support safety of angiogenic approaches in coronary artery disease

FDA approves Tivicay PD for children with HIV weighing at least 2kg

Tezspire meets Phase 3 endpoints in eosinophilic esophagitis

Brenntag signs Eastern Europe nutraceutical distribution deal

FDA approves daraxonrasib for second-line pancreatic cancer

PharmaForceIQ launches AI platform for pharma commercial teams

Biogen’s felzartamab approved in China for multiple myeloma

Agenus reports deep responses with immunotherapy in Phase 2 colon cancer study

CEPI funds Minapharm’s Phase 1 Bundibugyo Ebola vaccine programme

Sagimet prepares Phase 3 acne trial for first US patients

Circio and Full Circles Therapeutics combine technologies for in vivo cell therapy

main menu

recent posts

Ariadne Bio launches with Parkinson’s apathy drug candidate

MaaT Pharma to advance Phase 3 trial after EMA rejects MaaT013 application

Saudi Arabia announces biotech deals and research partnerships worth SAR 5.5BN

get connected